Micreos Raises Euro 30 Million for Endolysin Technology Set to...
THE HAGUE, Netherlands, March 29, 2019 /PRNewswire-AsiaNet/ -- Funding for clinical development program XZ.700 and Gladskin Eczema USA launch Dutch biotechnology company Micreos announced it has secured Euro30 million in funding to accelerate the development of its endolysin technology, set to replace ant...
Authors: LATEST ASIANET NEWS RELEASES